Skip to main content
Paul Kwo, MD, Gastroenterology, Stanford, CA

Paul Kwo MD

Hepatology & Liver Transplantation


Professor of Medicine, Stanford University

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Kwo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1992 - 1995
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1988 - 1991
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2025
  • IN State Medical License
    IN State Medical License 1995 - 2017
  • MN State Medical License
    MN State Medical License 1992 - 1995
  • MD State Medical License
    MD State Medical License 1990 - 1992
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology
  • Transplant Hepatology
    American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • Indianapolis Monthly Castle Connolly, 2007, 2009-2011, 2013
  • Fellow (FACG) American College of Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Diagnosis and Management of Primary Biliary Cholangitis  
    Zobair M Younossi, Kris V Kowdley, Ira M Jacobson, Mitchell L Shiffman, Paul Kwo, Nature
  • Response to Perrella Et Al  
    Paul Y Kwo, Mitchell L Shiffman, Nature

Lectures

  • Liver Transplantation: Selection and Controversies 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018
  • Viral Hepatitis: Where We Are in 2018 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/6/2018

Authored Content

  • Reflections on Key Presentations at ACG 2021November 2021

Press Mentions

  • In MASLD Patients, Bariatric Surgery Shows Better 5-Year Survival Than Weight-Loss Meds
    In MASLD Patients, Bariatric Surgery Shows Better 5-Year Survival Than Weight-Loss MedsFebruary 17th, 2025
  • DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial
    DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a TrialMay 7th, 2019
  • DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results
    DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial ResultsMay 3rd, 2019
  • Join now to see all

Grant Support

  • Alcohol Utilization Rates Determined By Alcohol Clamping--Effect Of Age, GenderNational Center For Research Resources1997–2002

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: